Riccardo Ricotta
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study.
Journal: Frontiers in oncology
Published: November 25, 2025
Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspective.
Journal: Expert review of anticancer therapy
Published: November 01, 2025
Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectives.
Journal: Expert review of anticancer therapy
Published: June 21, 2025
Efficacy of immune checkpoint inhibitors (ICIs) in PD-L1 negative Non-Small Cell Lung Cancer (NSCLC) - A meta-analysis based on reconstructed individual participant data.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2025
Clinical needs and pathology's answers in neuroendocrine neoplasms of the lung.
Journal: Pathologica
Published: March 05, 2025
Effect of immune checkpoint inhibitor therapy on biventricular mechanics in cancer patients over a short-term follow-up: a systematic review.
Journal: Frontiers in immunology
Published: February 13, 2025
Insulin resistance and cancer: molecular links and clinical perspectives.
Journal: Molecular and cellular biochemistry
Published: December 18, 2024
Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study.
Journal: Clinical genitourinary cancer
Published: September 09, 2024
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC.
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC.
Journal: Expert review of anticancer therapy
Published: April 17, 2024
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Journal: Cancer immunology, immunotherapy : CII
Published: February 25, 2024
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
Journal: Frontiers in immunology
Published: December 24, 2023
Last Updated: 09/26/2026